The document appears to be a market report containing sales data for pharmaceutical drugs. It includes sales figures in terms of volume (number of prescriptions) and value (dollars) for various drugs across months and years. It compares individual drug performance to overall market benchmarks and competitors. Specific drugs mentioned include those targeting epilepsy, anxiety, and seizures, among the top selling drugs for companies Ranbaxy and Solus.

1. GR% GR% GR%
JUL'13 JUL'14 JUL'13 JUL'14 JUL'14 JUL'13 JUL'14 JUL'13 JUL'14 JUL'14 JUL'13 JUL'14 JUL'13 JUL'14 JUL'14
- Ranbaxy SolusRanbaxy Solus 111101 715.22 824.35 100.00 100.00 15.26 2111.74 2431.32 100.00 100.00 15.13 4847.47 5465.66 100.00 100.00 12.75
- Ranbaxy SolusRanbaxy Solus 197906 37.09 44.68 5.19 5.42 20.48 108.08 131.85 5.12 5.42 21.99 248.67 291.85 5.13 5.34 17.36
GR% GR% GR%
JUL'13 JUL'14 JUL'13 JUL'14 JUL'14 JUL'13 JUL'14 JUL'13 JUL'14 JUL'14 JUL'13 JUL'14 JUL'13 JUL'14 JUL'14
- Ranbaxy Solus CareRanbaxy Solus Care 111101 1011.17 1144.10 100.00 100.00 13.15 2970.16 3352.21 100.00 100.00 12.86 6876.56 7543.66 100.00 100.00 9.70
- Ranbaxy Solus CareRanbaxy Solus Care 199710 20.96 25.48 2.07 2.23 21.59 59.21 73.46 1.99 2.19 24.07 136.87 165.65 1.99 2.20 21.03
RANKMKT/BRANDCORP_DIVISON - 2014 BRANDLAUNCH
MTHvalues in Mio's YTDvalues in Mio's
Val MS % Val MS % Val MS %
QTRvalues in Mio's
2MKT/BRANDCORP_DIVISON - 2014 BRANDLAUNCH
MTHvalues in Mio's YTDvalues in Mio's
Val MS % Val MS % Val MS %
QTRvalues in Mio's
Rx '000's Dr. '00's P/D/M Rx MS% Rx Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth %
N 3AS DIVALPROEX 131.7 23.1 57 100.0 (4.6) 655.7 24.1 54 100.0 (8.3) 1,669.8 23.7 59 100.0 (2.4)
4 DESVAL-ER - TAB--RBX (NCAS) 13.05 6.73 19 9.9 5.9 78.42 7.73 20 12.0 48.9 180.97 7.92 19 10.8 65.1
1 DEPAKOTE - TAB--SAV (NCAS) 30.64 8.85 35 23.3 (9.8) 154.73 8.53 36 23.6 (13.6) 409.73 7.68 44 24.5 5.1
2 DICORATE ER - TAB--SUN (NCAS) 33.58 15.33 22 25.5 (1.6) 154.78 14.74 21 23.6 (12.0) 387.62 14.52 22 23.2 1.4
3 DIVAA - TAB--INT (NCAS) 23.32 10.03 23 17.7 11.4 104.49 9.73 21 15.9 13.3 274.41 9.53 24 16.4 24.9
5 VALANCE - TAB--ABH (NCAS) 10.29 7.93 13 7.8 8.0 53.41 7.64 14 8.1 (3.9) 126.87 7.55 14 7.6 (16.9)
6 TREND XR - TAB--TRT (NCAS) 5.00 2.75 18 3.8 19.2 29.07 3.24 18 4.4 (18.8) 83.13 2.94 24 5.0 (38.7)
7 TIKOPREX - TAB--USV (NCAS) 3.60 3.40 11 2.7 (30.0) 14.44 3.04 9 2.2 (67.1) 51.60 3.36 13 3.1 (50.6)
8 VALKEM-OD - TAB--ALK (NCAS) 1.27 1.85 7 1.0 (72.2) 10.61 2.17 10 1.6 (44.4) 29.24 1.93 13 1.8 (32.5)
Rank Companies / Speacility
MTH YTD MAT
BU Solus & Solus Care Mkt
5 2 15 47 11 43 9 41
Rx '000's Dr. '00's P/D/M Rx MS% Rx Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth %
N 3AE CLOBAZAM 103.1 34.5 30 100.0 4.2 510.2 34.3 30 100.0 17.0 1,204.3 34.9 29 100.0 16.6
4 SOLZAM - TAB--RBX (NCAE) 8.47 7.73 11 8.2 303.9 40.50 7.71 11 7.9 247.9 79.85 7.20 9 6.6 131.8
1 FRISIUM - TAB--SAV (NCAE) 33.51 22.87 15 32.5 (6.7) 188.77 24.28 16 37.0 (2.6) 454.30 24.72 15 37.7 1.1
2 LOBAZAM - TAB--SUN (NCAE) 38.89 21.51 18 37.7 (10.1) 173.11 17.85 19 33.9 10.5 432.33 18.40 20 35.9 18.1
3 CLOBA - TAB--INT (NCAE) 17.09 9.24 18 16.6 51.1 72.23 10.02 14 14.2 42.5 152.68 10.16 13 12.7 17.8
5 CLOBATOR - TAB--TRT (NCAE) 1.95 3.17 6 1.9 (17.8) 9.52 2.54 7 1.9 32.5 31.74 3.42 8 2.6 45.1
6 CLOZAM - TAB--ABH (NCAE) 0.95 0.88 11 0.9 (51.5) 7.97 2.54 6 1.6 (2.7) 24.89 2.89 7 2.1 24.4
7 CLOBAKEM - TAB--ALK (NCAE) 0.39 0.37 11 0.4 (65.0) 9.29 1.92 10 1.8 113.2 12.89 1.24 9 1.1 59.4
8 CZAM - TAB--ETW (NCAE) 0.59 0.84 7 0.6 (48.7) 2.57 0.75 7 0.5 (46.6) 9.41 0.70 11 0.8 44.5
N 3AE CLOBAZAM Specility Neurologist Neuro Surgeon
Rank Companies / Speacility
MTH YTD MAT
Rx Trend in '000's Dr. Trendin '00's
BU Solus & Solus Care Mkt
5 2 15 47 11 43 9 41
Rx '000's Dr. '00's P/D/M Rx MS% Rx Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth %
N 3AE CLOBAZAM 103.1 34.5 30 100.0 4.2 510.2 34.3 30 100.0 17.0 1,204.3 34.9 29 100.0 16.6
4 SOLZAM - TAB--RBX (NCAE) 8.47 7.73 11 8.2 303.9 40.50 7.71 11 7.9 247.9 79.85 7.20 9 6.6 131.8
1 FRISIUM - TAB--SAV (NCAE) 33.51 22.87 15 32.5 (6.7) 188.77 24.28 16 37.0 (2.6) 454.30 24.72 15 37.7 1.1
2 LOBAZAM - TAB--SUN (NCAE) 38.89 21.51 18 37.7 (10.1) 173.11 17.85 19 33.9 10.5 432.33 18.40 20 35.9 18.1
3 CLOBA - TAB--INT (NCAE) 17.09 9.24 18 16.6 51.1 72.23 10.02 14 14.2 42.5 152.68 10.16 13 12.7 17.8
5 CLOBATOR - TAB--TRT (NCAE) 1.95 3.17 6 1.9 (17.8) 9.52 2.54 7 1.9 32.5 31.74 3.42 8 2.6 45.1
6 CLOZAM - TAB--ABH (NCAE) 0.95 0.88 11 0.9 (51.5) 7.97 2.54 6 1.6 (2.7) 24.89 2.89 7 2.1 24.4
7 CLOBAKEM - TAB--ALK (NCAE) 0.39 0.37 11 0.4 (65.0) 9.29 1.92 10 1.8 113.2 12.89 1.24 9 1.1 59.4
8 CZAM - TAB--ETW (NCAE) 0.59 0.84 7 0.6 (48.7) 2.57 0.75 7 0.5 (46.6) 9.41 0.70 11 0.8 44.5
N 3AE CLOBAZAM Specility Neurologist Neuro Surgeon
Rank Companies / Speacility
MTH YTD MAT
Rx Trend in '000's Dr. Trend in '00's

2. BU Solus & Solus Care Mkt
5 2 15 47 11 43 9 41
Rx '000's Dr. '00's P/D/M Rx MS% Rx Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth %
N 3AS DIVALPROEX 94.4 30.9 31 100.0 4.2 479.5 31.2 31 100.0 3.1 1,147.2 31.3 31 100.0 5.8
3 DESVAL-ER - TAB--RBX (NCAS) 13.56 8.97 15 14.4 (0.8) 75.00 8.92 17 15.6 25.2 179.27 10.78 14 15.6 36.3
1 DICORATE ER - TAB--SUN (NCAS) 22.24 12.48 18 23.6 (17.1) 113.38 12.89 18 23.6 (22.8) 289.82 12.20 20 25.3 (9.0)
2 VALANCE - TAB--ABH (NCAS) 16.68 13.79 12 17.7 17.2 84.50 13.13 13 17.6 31.6 187.18 13.02 12 16.3 15.6
4 DIVAA - TAB--INT (NCAS) 9.43 8.97 11 10.0 (3.3) 48.09 12.05 8 10.0 (2.9) 136.06 11.51 10 11.9 0.7
5 TIKOPREX - TAB--USV (NCAS) 5.93 0.90 66 6.3 115.5 26.09 1.46 36 5.4 48.6 54.55 1.34 34 4.8 31.1
6 DIVALEP ER - TAB--ABH (NCAS) 5.27 0.86 61 5.6 43.3 21.19 0.71 60 4.4 1.7 47.37 0.62 64 4.1 82.7
7 DAYO-OD - TAB--LUP (NCAS) 2.29 3.39 7 2.4 (22.0) 20.76 4.25 10 4.3 26.7 44.02 3.96 9 3.8 25.5
8 DIVALIN-OD - TAB--MKI (NCAS) 2.14 0.54 40 2.3 (18.9) 13.94 0.56 50 2.9 4.9 36.14 0.92 33 3.2 19.8
N 3AS DIVALPROEX Specility Neurologist Neuro Surgeon
Rank Companies / Speacility
MTH YTD MAT
BU Solus & Solus Care Mkt
5 2 15 47 11 43 9 41
Rx '000's Dr. '00's P/D/M Rx MS% Rx Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth %
N 3AT LEVETIRACETAM 146.0 41.4 35 100.0 10.0 698.9 42.2 33 100.0 11.4 1,593.9 40.5 33 100.0 16.2
6 LEVROXA - TAB--RBX (NCAT) 3.59 4.55 8 2.5 (10.1) 24.55 5.32 9 3.5 1.4 68.74 5.68 10 4.3 92.9
32 LEVROXA - INJ--RBX (NCAT) 0.00 0.00 0.0 0.37 0.21 3 0.1 0.42 0.12 3 0.0
1 LEVIPIL - TAB--SUN (NCAT) 43.18 27.30 16 29.6 3.8 194.15 27.86 14 27.8 (3.6) 473.92 26.79 15 29.7 9.7
2 LEVESAM - TAB--ABH (NCAT) 18.03 8.88 20 12.4 (34.3) 93.16 10.41 18 13.3 (6.2) 231.90 10.07 19 14.5 23.1
3 LEVERA - TAB--INT (NCAT) 17.38 19.27 9 11.9 (1.9) 87.85 17.54 10 12.6 (0.6) 197.68 17.11 10 12.4 0.3
4 EPILIVE - TAB--LUP (NCAT) 22.04 11.16 20 15.1 188.5 96.38 10.67 18 13.8 155.2 169.49 9.33 15 10.6 62.5
5 LEVACETAM - TAB--MCL (NCAT) 8.42 4.59 18 5.8 17.0 36.86 3.83 19 5.3 (16.4) 91.17 4.16 18 5.7 (0.3)
7 TORLEVA - TAB--TRT (NCAT) 5.62 10.16 6 3.9 (3.6) 29.09 9.09 6 4.2 (4.5) 64.20 7.32 7 4.0 (20.6)
N 3AT LEVETIRACETAM Specility Neurologist Neuro Surgeon
Rank Companies / Speacility
MTH YTD MAT
Rx Trend in '000's Dr. Trendin '00's
Rx '000's Dr. '00's P/D/M Rx MS% Rx Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth %
N 6AD SERTRALINE 22.3 18.0 12 100.0 1.1 103.6 15.9 13 100.0 10.8 222.4 14.6 13 100.0 2.0
3 SERLIFT - TAB--RBX (NFAD) 2.18 3.53 6 9.8 (48.1) 15.06 3.70 8 14.5 32.0 44.87 3.89 10 20.2 48.9
1 SERTA - TAB--UCL (NFAD) 6.27 8.08 8 28.1 (11.5) 35.54 6.93 10 34.3 9.7 72.54 6.48 9 32.6 8.9
2 DAXID - TAB--PFZ (NFAD) 7.91 4.53 17 35.4 14.5 26.79 5.27 10 25.8 (20.6) 55.70 5.26 9 25.0 (31.9)
4 ZOSERT - TAB--SUN (NFAD) 2.12 3.90 5 9.5 3.1 8.24 2.78 6 8.0 19.7 15.59 1.97 7 7.0 (5.8)
5 SERENE - TAB--APX (NFAD) 1.90 1.15 16 8.5 8.77 1.09 16 8.5 713.9 14.84 0.82 15 6.7 1,276.3
6 SERTIN - TAB--TAS (NFAD) 0.94 0.29 32 4.2 39.9 5.53 0.33 34 5.3 83.7 9.69 0.31 26 4.4 (0.4)
7 INOSERT - TAB--IPC (NFAD) 0.62 2.07 3 2.8 1.22 0.83 3 1.2 181.7 2.90 0.81 3 1.3 51.3
8 S R T - TAB--SHI (NFAD) 0.11 0.30 4 0.5 (70.2) 0.87 0.27 6 0.8 (40.5) 2.04 0.38 5 0.9 5.7
Rank Companies / Speacility
MTH YTD MAT

3. BU Solus & Solus Care Mkt
5 2 15 47 11 43 9 41
Rx '000's Dr. '00's P/D/M Rx MS% Rx Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth %
N 6AD SERTRALINE 74.9 17.9 42 100.0 7.3 350.3 18.5 38 100.0 8.9 831.2 17.6 39 100.0 14.8
4 SERLIFT - TAB--RBX (NFAD) 7.67 3.77 20 10.2 37.6 40.57 4.59 18 11.6 181.4 92.15 4.47 17 11.1 251.0
1 SERTA - TAB--UCL (NFAD) 33.01 11.30 29 44.1 24.7 154.39 11.30 27 44.1 1.8 352.42 10.26 29 42.4 4.4
2 DAXID - TAB--PFZ (NFAD) 12.27 6.70 18 16.4 (16.1) 61.15 7.99 15 17.5 0.7 153.95 7.81 16 18.5 12.5
3 ZOSERT - TAB--SUN (NFAD) 9.20 5.25 18 12.3 (13.1) 35.32 5.06 14 10.1 14.4 95.75 4.94 16 11.5 54.9
5 SERENATA - TAB--TRT (NFAD) 6.87 2.54 27 9.2 47.8 21.68 2.46 18 6.2 (9.3) 43.52 2.24 16 5.2 (34.4)
6 SERTIMA - TAB--INT (NFAD) 1.07 0.80 13 1.4 (58.6) 7.78 1.18 13 2.2 (49.8) 26.37 1.37 16 3.2 (31.2)
7 TRALIN - TAB--ALK (NFAD) 0.77 1.63 5 1.0 17.0 10.83 1.63 13 3.1 341.5 25.53 1.41 15 3.1 236.5
8 DEPSERT - TAB--REL (NFAD) 1.86 1.86 10 2.5 123.0 8.37 1.48 11 2.4 41.5 14.35 1.24 10 1.7 (28.0)
N 6AD SERTRALINE Specility Psychiatrist
Rank Companies / Speacility
MTH YTD MAT
BU Solus & Solus Care Mkt
5 2 15 47 11 43 9 41
Rx '000's Dr. '00's P/D/M Rx MS% Rx Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth % Rx '000's Dr. '00's P/D/M Rx MS% Gth %
N 3AS DIVALPROEX 131.7 23.1 57 100.0 (4.6) 655.7 24.1 54 100.0 (8.3) 1,669.8 23.7 59 100.0 (2.4)
4 DESVAL-ER - TAB--RBX (NCAS) 13.05 6.73 19 9.9 5.9 78.42 7.73 20 12.0 48.9 180.97 7.92 19 10.8 65.1
1 DEPAKOTE - TAB--SAV (NCAS) 30.64 8.85 35 23.3 (9.8) 154.73 8.53 36 23.6 (13.6) 409.73 7.68 44 24.5 5.1
2 DICORATE ER - TAB--SUN (NCAS) 33.58 15.33 22 25.5 (1.6) 154.78 14.74 21 23.6 (12.0) 387.62 14.52 22 23.2 1.4
3 DIVAA - TAB--INT (NCAS) 23.32 10.03 23 17.7 11.4 104.49 9.73 21 15.9 13.3 274.41 9.53 24 16.4 24.9
5 VALANCE - TAB--ABH (NCAS) 10.29 7.93 13 7.8 8.0 53.41 7.64 14 8.1 (3.9) 126.87 7.55 14 7.6 (16.9)
6 TREND XR - TAB--TRT (NCAS) 5.00 2.75 18 3.8 19.2 29.07 3.24 18 4.4 (18.8) 83.13 2.94 24 5.0 (38.7)
7 TIKOPREX - TAB--USV (NCAS) 3.60 3.40 11 2.7 (30.0) 14.44 3.04 9 2.2 (67.1) 51.60 3.36 13 3.1 (50.6)
8 VALKEM-OD - TAB--ALK (NCAS) 1.27 1.85 7 1.0 (72.2) 10.61 2.17 10 1.6 (44.4) 29.24 1.93 13 1.8 (32.5)
N 3AS DIVALPROEX Specility Psychiatrist
Rank Companies / Speacility
MTH YTD MAT